rs8102892
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_032447.5(FBN3):c.6795C>T(p.Asn2265=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00739 in 1,612,238 control chromosomes in the GnomAD database, including 677 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.037 ( 360 hom., cov: 30)
Exomes 𝑓: 0.0043 ( 317 hom. )
Consequence
FBN3
NM_032447.5 synonymous
NM_032447.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.32
Genes affected
FBN3 (HGNC:18794): (fibrillin 3) This gene encodes a memebr of the fibrillin protein family. Fibrillins are extracellular matrix molecules that assemble into microfibrils in many connective tissues. This gene is most highly expressed in fetal tissues and its protein product is localized to extracellular microfibrils of developing skeletal elements, skin, lung, kidney, and skeletal muscle. This gene is potentially involved in Weill-Marchesani syndrome. [provided by RefSeq, Mar 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 19-8086285-G-A is Benign according to our data. Variant chr19-8086285-G-A is described in ClinVar as [Benign]. Clinvar id is 1562427.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.32 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.125 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBN3 | NM_032447.5 | c.6795C>T | p.Asn2265= | synonymous_variant | 55/64 | ENST00000600128.6 | NP_115823.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBN3 | ENST00000600128.6 | c.6795C>T | p.Asn2265= | synonymous_variant | 55/64 | 1 | NM_032447.5 | ENSP00000470498 | ||
FBN3 | ENST00000270509.6 | c.6795C>T | p.Asn2265= | synonymous_variant | 54/63 | 1 | ENSP00000270509 | |||
FBN3 | ENST00000601739.5 | c.6795C>T | p.Asn2265= | synonymous_variant | 55/64 | 1 | ENSP00000472324 | |||
FBN3 | ENST00000651877.1 | c.6921C>T | p.Asn2307= | synonymous_variant | 55/64 | ENSP00000498507 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0373 AC: 5666AN: 151882Hom.: 361 Cov.: 30
GnomAD3 genomes
AF:
AC:
5666
AN:
151882
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0107 AC: 2674AN: 249440Hom.: 149 AF XY: 0.00798 AC XY: 1077AN XY: 134990
GnomAD3 exomes
AF:
AC:
2674
AN:
249440
Hom.:
AF XY:
AC XY:
1077
AN XY:
134990
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00427 AC: 6235AN: 1460244Hom.: 317 Cov.: 32 AF XY: 0.00383 AC XY: 2785AN XY: 726474
GnomAD4 exome
AF:
AC:
6235
AN:
1460244
Hom.:
Cov.:
32
AF XY:
AC XY:
2785
AN XY:
726474
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0374 AC: 5679AN: 151994Hom.: 360 Cov.: 30 AF XY: 0.0359 AC XY: 2667AN XY: 74294
GnomAD4 genome
AF:
AC:
5679
AN:
151994
Hom.:
Cov.:
30
AF XY:
AC XY:
2667
AN XY:
74294
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
29
AN:
3476
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
FBN3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 19, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at